Study of methods for state regulation of prices and costs of the health care system for medicines in the United Kingdom
Objective: analysis of state regulation of prices and costs for the purchase of medicines (drugs) in the United Kingdom (UK), and proposal development to improve the processes of state regulation of manufacturers’ marginal registered prices of medicines included in the list of vital and essential dr...
Saved in:
| Main Authors: | A. A. Leshkevich, D. S. Yurochkin, Z. M. Golant, I. A. Narkevich |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2022-04-01
|
| Series: | Фармакоэкономика |
| Subjects: | |
| Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/656 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Review of calculation methods, procedures for registration and re-registration of producer prices of medicines in the countries of the Eurasian Economic Union
by: A. A. Leshkevich, et al.
Published: (2020-08-01) -
Reimbursement prices of new, innovative medicines in Germany: a comparison of negotiation and cost-effectiveness analysis
by: Afschin Gandjour -
Monitoring the impact of regulatory measures on medicine pricing in Thailand: an observation over a 16-year span
by: Chaoncin Sooksriwong, et al.
Published: (2025-12-01) -
OVERVIEW OF THE KEY AMENDMENTS TO THE RULES OF THE STATE REGISTRATION OF MAXIMUM SELLING PRICES FOR MEDICINES INCLUDED INTO THE LIST OF ESSENTIAL AND VITALLY IMPORTANT PRODUCTS
by: A. G. Odabashian, et al.
Published: (2019-01-01) -
Cardiovascular medicine prices as an indicator of access to medicines and their rational use
by: C M. Razzakova, et al.
Published: (2019-05-01)